SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kane MA. Global status of hepatitis B immunization. Lancet 1996; 348:696.MEDLINE
  • 2
    Shapiro CN. Epidemiology of hepatitis B. Pediatr Infect Dis J 1993; 12:433437.MEDLINE
  • 3
    United Network of Organ Sharing—UNOS scientific registry data, Transplant Recipients Characteristics—1988-1997, Table 22, September 1998.
  • 4
    European Liver Transplant Registry—ELTR. Registry for the European Liver Transplant Association, data analysis, 05/1968-12/1997, http://www-eltr.vjf.inserm.fr.
  • 5
    Todo S, Demetris A, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus related liver disease. Hepatology 1991; 13:619626.MEDLINE
  • 6
    O'Grady JG, Smith HM, Davies SE, Daniels HM, Donaldson PT, Tan KC, Portmann B, et al. Hepatitis B virus re-infection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol 1992; 14:104111.MEDLINE
  • 7
    Davies SE, Portman BC, O'Grady JG, Aldis PM, Chaggar K, Alexander GJ, Williams R. Hepatic histologic findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13:150157.MEDLINE
  • 8
    Medicare program: criteria for Medicare coverage of adult liver transplants—HCFA. Final notice. Fed Regist 1991; 56:1500615018.MEDLINE
  • 9
    Samuel D, Müller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H. Liver transplantation in European patients with the hepatitis B surfaces antigen. N Engl J Med 1993; 329:18421847.MEDLINE
  • 10
    Samuel D, Bismuth H. Liver transplantation for hepatitis B. Gastroenterol Clin North Am 1993; 22:271283.MEDLINE
  • 11
    Terrault N, Wright TL. Hepatitis B virus infection and liver transplantation. Gut 1997; 40:568571.MEDLINE
  • 12
    Lucey MR, Graham DM, Martin P, Di-Bisceglie A, Rosenthal S, Waggoner JG, Merion RM, et al. Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation. Gut 1992; 33:13901396.MEDLINE
  • 13
    Johnson PJ, Wansbrough-Jones MH, Portmann B. Familial HBsAg positive hepatoma: treatment with orthotopic liver transplantation and specific immune globulin. BMJ 1978; 1:278.MEDLINE
  • 14
    Lauchart W, Müller R, Pichlmayr R. Long-term immunoprophylaxis of hepatitis B virus re-infection in recipients of human liver grafts. Transplant Proc 1987; XIX:40514053.
  • 15
    Müller R, Samuel D, Fassati LR, Benhamou JP, Bismuth H, Alexander GJM. Eurohep consensus report on the management of liver transplantation for hepatitis B virus infection. J Hepatol 1994; 21:11401143.MEDLINE
  • 16
    Blumhardt G, Neuhaus WD, Bechstein L, Steffen R, Hopf U, Moller B, Raakow R, et al. Liver transplantation in HBsAg positive patients. Transplant Proc 1990; 22:15771578.
  • 17
    McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, McCullough CS, Dickson RC, Caldwell SH, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996; 61:13581364.MEDLINE
  • 18
    al-Hemsi B, McGory RW, Shepard B, Ishitani MB, Stevenson WC, McCullough C, Pruett TL. Liver transplantation for hepatitis B cirrhosis: clinical sequela of passive immunization. Clin Transplant 1996; 10:668675.MEDLINE
  • 19
    Sawyer RG, McGory RW, Gaffey MJ, McCullough CC, Shephard BL, Houlgrave CW, Ryan TS, et al. Improved clinical outcome with liver transplantation for hepatitis B related cirrhosis. Ann Surg 1998; 227:841850.MEDLINE
  • 20
    Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immune globulin. Hepatology 1996; 24:13271333.MEDLINE
  • 21
    König V, Hopf U, Neuhaus P, Bauditz J, Schmidt CA, Blumhardt G, Bechstein WO, et al. Long-term follow up of hepatitis B virus infected recipients after orthotopic liver transplantation. Transplantation 1994; 58:553559.MEDLINE
  • 22
    Langrehr JM, Lemmens HP, Lohmann R, Neumann U, Muller AR, Platz KP, Kling N, et al. Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis. Transplant Proc 1995; 26:12151216.
  • 23
    Devlin J, Smith HM, O'Grady JG, Portmann B, Tan KC, Williams R. Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipients. J Hepatol 1994; 21:204210.MEDLINE
  • 24
    Grazi GL, Mazziotti A, Sama C, Jovine E, Stefanini F, Paladini R, Rossi R, et al. Liver transplantation in HBsAg-positive HBV-DNANnegative cirrhotics: immunoprophylaxis and long-term outcome. Liver Transpl Surg 1996; 2:418425.MEDLINE
  • 25
    Gugenheim J, Baldini E, Ouzan D, Mouiel J. Absence of initial viral replication and long-term high dose immune globulin administration improve results of hepatitis B virus recurrence prophylaxis after liver transplantation. Transplant Proc 1997; 29:517518.MEDLINE
  • 26
    Lerut JP, Donataccio M, Ciccarelli O, Roggen F, Jamart J, Laterre PF, Cornu C, et al. Liver transplantation and HBsAg-positive postnecrotic cirrhosis: adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis. J Hepatol 1999; 30:706714.MEDLINE
  • 27
    Samuel D, Bismuth A, Mathieu D, Arulnaden JL, Reynes M, Benhamou JP, Brechot C, et al. Passive immunoprophylaxis after liver transplantation in HBsAg+ patients. Lancet 1991; 337:813815.MEDLINE
  • 28
    Lemmens HP, Langrehr JM, Blumhardt G, Lohmann R, Knoop M, Verschl J, Schattenfroh N, et al. Outcome following orthotopic liver transplantation in HBsAg positive patients using short or long term immunoprophylaxis. Transplant Proc 1994; 26:36223623.MEDLINE
  • 29
    Gugenheim J, Crafa F, Fabiani P, Militerno G, Goubaux B, Saint-Paul MC, Uzan D, et al. Recurrence of virus B hepatitis after liver transplantation. Gastroenterol Clin Biol 1992; 16:430433.MEDLINE
  • 30
    Nymann T, Shokouh-Amiri MH, Vera SR, Riely CA, Alloway RR, Gaber AO. Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIG) prophylaxis after liver transplantation. Clin Transplant 1996; 10:663667.MEDLINE
  • 31
    Adler R, Safadi R, Caraco Y, Rowe M, Etzioni A, Ashur Y, Shouval D. Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in-patients after liver transplantation. Hepatology 1999; 29:12991305.MEDLINE
  • 32
    Lee WC, Jerry LB, Wang CC, Chen MF, Chien RN, Chiu CT, Ling DY, et al. Long-term immunoprophylaxis for hepatitis B virus re-infection after liver transplantation. Transplant Proc 1996; 28:16991700.MEDLINE
  • 33
    Angus PW. Review: hepatitis B and liver transplantation. J Gastroenterol Hepatol 1997; 12:217223.MEDLINE
  • 34
    Grellier L, Dusheiko GM. Hepatitis B virus and liver transplantation: concepts in antiviral prophylaxis. J Viral Hepat 1997; 4:111S116S.
  • 35
    Waters JA, Brown SE, Steward WN. Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response. Virus Res 1992; 33:112.
  • 36
    Wahl M, Iwarson S, Snoy P, Gerety RJ. Failure of hepatitis B immuneglobuline to protect against experimental infection in chimpanzees. J Hepatol 1989; 9:198203MEDLINE
  • 37
    Celis E, Abraham KG, Miller RW. Modulation of the immunological response to hepatitis B virus by antibodies. Hepatology 1987; 7:763769.
  • 38
    Rath S, Devey ME. IgG subclass composition of antibodies to HBsAg in circulating immune complexes from patients with hepatitis B virus infection. Clin Exp Immunol 1988; 72:164167.MEDLINE
  • 39
    Ackerman Z, Wands JR, Gazitt Y, Brechot C, Kew M, Shouval D. Enhancement of HBsAg detection in serum of anti-HBc positive patients following removal of circulating immune complexes. J Hepatol 1994; 20:398404.MEDLINE
  • 40
    Yu Z, Lennon VA. Mechanism of intravenous immune globuline in antibody mediated autoimmune disease. N Engl J Med 1999; 340:227228.MEDLINE
  • 41
    Farges O, Saliba F, Fahramant H, Samuel D, Bismuth A, Bismuth H. Incidence of acute and chronic rejection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology 1996; 23:240248.MEDLINE
  • 42
    Burbach GJ, Bienzle U, Neuhaus R, Hopf U, Metzger WG, Pratschke J, Neuhaus P. Intravenous or intramuscular anti-HBs immune globulin for the prevention of hepatitis B re-infection after orthotopic liver transplantation. Transplantation 1997; 63:478480.MEDLINE
  • 43
    Tchervenkov JI, Tector AJ, Barkun JS, Sherker A, Forbers CD, Elias N, Cantarovich M, et al. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant. Ann Surg 1997; 226:356368.MEDLINE
  • 44
    Yao FY, Osorio RW, Roberts JP, Poordad FF, Briceno MN, Garcia-Kennedy R, Gish RR. Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation. Liver Transpl Surg 5; 1999:491496.
  • 45
    Yoshida EM, Erb SR, Partovi N, Scudamore CH, Chung SW, Frighetto L, Eggen HJ, et al. Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin. Liver Transpl Surg 1999; 5:520525.MEDLINE
  • 46
    Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci U S A 1996; 93:43984402.MEDLINE
  • 47
    Tur-Kaspa R, Burk RD, Shaul Y, Shafritz D. Hepatitis B virus DNA contains a glucocorticoid responsive element. Proc Natl Acad Sci U S A 1986; 83:16271631.MEDLINE
  • 48
    Feray C, Zignego AL, Samuel D, Bismuth A, Reynes M, Tiollais P, Bismuth H, et al. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. Transplantation 1990; 49:11551158.MEDLINE
  • 49
    Barker LF, Lorenz D, Rastogi SC, Gerety RJ, Finlayson JS, Seligmann EB. Study of proposed international reference preparation hepatitis B immune globulin. WHO expert committee on biological standardization. WHO/BS 1977; 77.1164:117.
  • 50
    Stamm B, Gerlich W, Thomssen R. Quantitative determination of antibodies against hepatitis B surface antigen: measurements of its binding capacity. J Biol Standard 1980; 8:5968.
  • 51
    Scheiermann N. Kuwert EK. Uptake and elimination of hepatitis B immune globulins after intramuscular application in man. Dev Biol Standard 1983; 54:347355.
  • 52
    Stephan W, Fasold H. Intravenöses human immunoglobulin durch chemische modifizierung mit beta propiolacton. Radiochemische Unterschungen [in German]. Arzneim Forschung 1980; 12:20902093.
  • 53
    Wahl M, Hermodsson S, Kjellman H, Iwarson S. Recovery and turnover of hepatitis B immuneglobulin in volunteers. Dev Biol Standard 1983; 54:341345.
  • 54
    Glöckner WM. Kinetik von immunglobulin G nach intravenöser oder intramuskulärer applikation. In: KornhuberB, CastroLA, eds. Patient-Infektion-Immunglobulin Munchen. Berlin-Heidelberg: Springer-Verlag, 1984:3338.
  • 55
    Branger M, Elias A, Vitrano L, Jaulin P. Collection of anti-HBs hyperimmune plasma: stimulation by Genhevac B in weakly immunized donors. Rev Fr Transfus Hemobiol 1992; 35:325334.MEDLINE
  • 56
    Nityanand S, Holm G, Lefvert AK. Immune complex mediated vasculitis in hepatitis B and C infections and the effects of anti-viral therapy. Clin Immunol Immuno Pathol 1997; 82:250257.
  • 57
    Raz E, Michaeli J, Brezis M, Popovtzer MM, Gazitt Y, Shouval D. Improvement of immune-complex nephritis associated with hepatitis B surface antigen excess. Am J Nephrol 1989; 9:162166.MEDLINE
  • 58
    Lowell JA, Burgess S, Shenoy S, Curci JA, Peters M, Howard TK. Mercury poisoning associated with high dose hepatitis BNimmune globulin administration after liver transplantation for chronic hepatitis B. Liver Transpl Surg 1996; 2:475478.MEDLINE
  • 59
    Dodd RY. Infectious risk of plasma donations: relationship to safety of intravenous immune globulins. Clin Exp Immunol 1996; 104:31S34S.
  • 60
    Feray C, Gigou M, Samuel D, Ducot B, Maisonneuve P, Reynes M. Incidence of hepatitis C in patients receiving different preparations of hepatitis B immune globulins after liver transplantation. Ann Intern Med 1998; 128:810816.MEDLINE
  • 61
    Hunt CM, McGill JM, Allen MI, Condreay LD. Clinical relevance of hepatitis B viral mutations. Concise Review. Hepatology 2000; 31:10371044.MEDLINE
  • 62
    Locarnini S, Birch C. Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients. J Hepatol 1999; 30:536550.MEDLINE
  • 63
    Oon CJ, Lim GK, Ye Z, Goh KT, Tan KL, Yo SL, Hopes E, et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 1995; 13:699702.MEDLINE
  • 64
    Trautwein C, Schrem H, Tillmann HL, Kubicka S, Walker D, Boker KH, Maschek HJ, et al. Hepatitis B virus mutations in the Pre-S genome before and after liver transplantation. Hepatology 1996; 24:482488.MEDLINE
  • 65
    Carman WF, Trautwein C, van-Deursen FJ, Coleman K, Dornan E, McIntyre G, Waters J, et al. Hepatitis B virus envelope variations after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 1996; 24:489493.MEDLINE
  • 66
    Sterneck M, Gunther S, Gerlach J, Naoumov NV, Santatonio T, Fischer L, Rogiers X, et al. Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis. J Hepatol 1997; 26:754764.MEDLINE
  • 67
    Ghany GM, Ayola B, Villamil F, Gish RG, Rojter S, Vierling JM, Lok A. Hepatitis B virus mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998; 27:213222.MEDLINE
  • 68
    Terrault NA, Zhou S, McCory RW, Pruett TL, Lake JR, Roberts JP, Ascher NL, et al. Incidence and clinical significance of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology 1998; 28:555561.MEDLINE
  • 69
    Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer-zum-Buschenfelde KH, Neuhaus P, et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high dose hepatitis B immune globulin after liver transplantation Hepatology 1998; 27:254263.
  • 70
    McMahon G, Ehrlich PH, Moustafa ZA, McCarthy LA, Dottavio D, Tolpin MD, Nadler PL, et al. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological assay of recurrent HBsAg derived from monoclonal antibodyNtreated liver transplant recipients. Hepatology 1992; 15:757766.MEDLINE
  • 71
    Marcellin P, Samuel D, Areias J, Loriot MA, Arulnaden JL, Gigou M, David MF, et al. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis BNrelated end-stage liver disease. Hepatology 1994; 19:612.MEDLINE
  • 72
    Grellier L, Mutimer D, Ahmed M, Brown D, Burroughs AK, Rolles K, McMaster P, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348:12121215.MEDLINE
  • 73
    Bain GV, Kneteman NM, Ma MM, Gutfreund K, Shapiro JA, Fischer K, Tipples G, et al. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation 1996; 62:14561462.MEDLINE
  • 74
    Bartholomew MM, Jansen RW, Jeffers LJ, Reddy KR, Johnson LC, Bunzendahl H, Condreay LD, et al. Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997; 349:2022.MEDLINE
  • 75
    Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H, Goss JA, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination of lamivudine and hepatitis B immune globulin. Hepatology 1998; 28:585589.MEDLINE
  • 76
    Nery JR, Weppler D, Rodriguez M, Ruiz P, Schiff ER, Tzakis AG. Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation. Transplantation 1998; 65:16151621.MEDLINE
  • 77
    Mutimer D, Pillay D, Dragon E, Tang H, Ahmed M, O'Donnell K, Shaw J, et al. High pre-treatment serum hepatitis B virus titer predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation. J Hepatol 1999; 30:715721.MEDLINE
  • 78
    Kruger M, Tillman HL, Trautwein C, Bode U, Oldhafer K, Maschek H, Boker et al. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study. Liver Transplant Surg 1996; 2:253262.
  • 79
    Roche B, Samuel D, Gigou M, Feray C, Virot V, Majno P, Majno P, et al. Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantation. J Hepatol 1999; 31:584592MEDLINE
  • 80
    Boni C, Bertoletti A, Penna A, Cavalli A, Pilli M, Urbani S, Scognamiglio P, et al. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest 1998; 102:968975.MEDLINE
  • 81
    Perrillo R, Rakela J, Dienstag J, Levy G, Martin P, Wright T, Caldwell S, et al. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Hepatology 1999; 29:15811586.MEDLINE
  • 82
    Mutimer D, Pillay D, Shields P, Cane P, Ratcliffe D, Martin B, Buchaus, et al. Outcome of lamivudine resistant hepatitis B virus infection in liver transplant recipients. Gut 2000; 46:10113.
  • 83
    McCaughan GW, Spencer J, Koorey D, Bowden S, Bartholomeusz A, Littlejohn M, Verran D, et al. Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin. Liver Transpl Surg 1999; 5:512519.MEDLINE
  • 84
    Perrilo R, Schiff E, Yoshida E, Statler A, Hirsch K, Wright T, et al. Adefovir Dipivoxil for the treatment of lamivudine resistant hepatitis B mutants. Hepatology 2000;32:129134MEDLINE
  • 85
    Sanchez-Fueyo A, Rimola A, Grande L, Costa J, Mas A, Navasa M, Cirera I, et al. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: a new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. Hepatology 2000; 31:496501.MEDLINE
  • 86
    Eren R, Lubin I, Terkieltaub D, Ben-Moshe O, Zauberman A, Uhlmann R, Tzahor T, et al. Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system. Immunology 1998; 93:154161.MEDLINE
  • 87
    Dickson RC, Wright RM, Bacchetta MD, Bodily SE, Caldwell SH, Driscoll CJ, Pruett TL, et al. Quality of life of hepatitis B and C patients after liver transplantation. Clin Transplant 1997; 11:282285.MEDLINE
  • 88
    Vierling JM, Teperman LW, Brownstein AP (eds). Hepatitis B and liver transplantation. Semin Liver Dis 2000; 20:1S35S.